Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (231-240 of 607) with videos related to

Pageof 61
Sort By:
Clinical and Experimental Rheumatology|June 14, 2012
Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patientsCecilia Chighizola, Pier Luigi Meroni, Benjamin E Schreiber, et al.
JAMA Dermatology|May 26, 2021
A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis: A Narrative ReviewMichael Hughes, Yannick Allanore, Khadija El Aoufy, et al.
Clinical and Experimental Immunology|November 20, 1998
Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayersC P Denton, X Shi-Wen, A Sutton, et al.
The Journal of Rheumatology|April 15, 2025
Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III AntibodiesElizabeth R Volkmann, Shervin Assassi, Christopher P Denton, et al.
Respiratory Medicine|August 6, 2016
Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trialAryeh Fischer, Christopher P Denton, Marco Matucci-Cerinic, et al.
Rheumatology (Oxford, England)|April 28, 2021
Autoantibody predictors of gastrointestinal symptoms in systemic sclerosisFiza Ahmed, Rory H Maclean, Svetlana I Nihtyanova, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosisKorsa Khan, Shiwen Xu, Svetlana Nihtyanova, et al.
Rheumatology (Oxford, England)|April 20, 2001
Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survivalA J MacGregor, R Canavan, C Knight, et al.
Rheumatology (Oxford, England)|July 21, 2022
Macrophages as determinants and regulators of fibrosis in systemic sclerosisYehya Al-Adwi, Johanna Westra, Harry van Goor, et al.
Rheumatology (Oxford, England)|August 3, 2010
Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertensionChristopher J Valerio, Clive E Handler, Peter Kabunga, et al.
Pageof 61

Showing results (231-240 of 607) with videos related to

Sort By:
Pageof 61
Clinical and Experimental Rheumatology|June 14, 2012
Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patientsCecilia Chighizola, Pier Luigi Meroni, Benjamin E Schreiber, et al.
JAMA Dermatology|May 26, 2021
A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis: A Narrative ReviewMichael Hughes, Yannick Allanore, Khadija El Aoufy, et al.
Clinical and Experimental Immunology|November 20, 1998
Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayersC P Denton, X Shi-Wen, A Sutton, et al.
The Journal of Rheumatology|April 15, 2025
Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III AntibodiesElizabeth R Volkmann, Shervin Assassi, Christopher P Denton, et al.
Respiratory Medicine|August 6, 2016
Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trialAryeh Fischer, Christopher P Denton, Marco Matucci-Cerinic, et al.
Rheumatology (Oxford, England)|April 28, 2021
Autoantibody predictors of gastrointestinal symptoms in systemic sclerosisFiza Ahmed, Rory H Maclean, Svetlana I Nihtyanova, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosisKorsa Khan, Shiwen Xu, Svetlana Nihtyanova, et al.
Rheumatology (Oxford, England)|April 20, 2001
Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survivalA J MacGregor, R Canavan, C Knight, et al.
Rheumatology (Oxford, England)|July 21, 2022
Macrophages as determinants and regulators of fibrosis in systemic sclerosisYehya Al-Adwi, Johanna Westra, Harry van Goor, et al.
Rheumatology (Oxford, England)|August 3, 2010
Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertensionChristopher J Valerio, Clive E Handler, Peter Kabunga, et al.
Pageof 61